Related references
Note: Only part of the references are listed.Acotiamide hydrochloride (Z-338) enhances gastric motility and emptying by inhibiting acetylcholinesterase activity in rats
Masanao Kawachi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Serotonin release and uptake in the gastrointestinal tract
Paul P. Bertrand et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2010)
Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel Syndrome
Kazutoshi Hori et al.
GUT AND LIVER (2009)
TRPA1 agonists delay gastric emptying in rats through serotonergic pathways
Hitoshi Doihara et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
The effect of paroxetine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects
Takeshi Kadokura et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effects of serotonin 5-HT3 receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats
Takuya Hirata et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats:: Comparative studies with antidiarrheal and spasmolytic agents
Takuya Hirata et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats:: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer
T. Hirata et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome
Kei Matsueda et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Intestinal nutrients elicit satiation through concomitant activation of CCK1 and 5-HT3 receptors
David M. Savastano et al.
PHYSIOLOGY & BEHAVIOR (2007)
Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome
Takuya Hirata et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Functional CRF receptors in BON cells stimulate serotonin release
Bengt von Mentzer et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrain
David M. Savastano et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Functional dyspepsia: Are psychosocial factors of relevance?
Sandra Barry et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Functional gastroduodenal disorders
Jan Tack et al.
GASTROENTEROLOGY (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity:: implications for irritable bowel syndrome
Y Taché et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia
M Corsetti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT3 receptor antagonist, across the blood-brain barrier
C Yamamoto et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
Food and hypersensitivity in functional dyspepsia
NW Read
GUT (2002)
Enterogastric brake in rats with segmental bowel resection: Role of capsaicin-sensitive nerves
T Topcu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2002)
Share Paper
